Last updated on May 2020

Genomic BRCA and Extensive ovArian Cancer Testing

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Epithelial Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer
  • Age: Between 18 - 100 Years
  • Gender: Female

Inclusion Criteria:

  • Patient older than 18 years.
  • Patient with ovarian and/or primitive peritoneal and/or fallopian tubes carcinoma, histologically confirmed, with an advanced stage at diagnosis (stage III to IV FIGO 2014)
  • Patient in first line therapy
  • Available tumor sample fixed in formalin and included in paraffin (FFPE):
  • in pre-chemotherapy, insofar as possible
  • having a sufficient tumor surface, with a final cellularity of at least 20%
  • Identification of a molecular genetics' cancer platform and an onco-geneticists team working with the investigator team
  • Patient consenting her data to be collected and submitted through an automated processing
  • Patient beneficiary from the French social security

Exclusion Criteria:

  • Patient with a mucinous ovarian carcinoma
  • Patient pregnant or breastfeeding
  • Patient under legal protection (guardianship or court order) or unable to consent

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.